These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18976762)

  • 21. [Severe ovarian hyperstimulation syndrome treatment by decompressive paracentesis and self-transfusion of ascitis fluid].
    Kably Ambe A; Ruiz Anguas J; Sánchez de León A
    Ginecol Obstet Mex; 2006 Jun; 74(6):291-9. PubMed ID: 16970114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian salvage in bilaterally complicated severe ovarian hyperstimulation syndrome.
    Al Omari W; Ghazal-Aswad S; Sidky IH; Al Bassam MK
    Fertil Steril; 2011 Aug; 96(2):e77-9. PubMed ID: 21718996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outpatient management of severe ovarian hyperstimulation syndrome: a systematic review and a review of existing guidelines.
    Gebril A; Hamoda H; Mathur R
    Hum Fertil (Camb); 2018 Jun; 21(2):98-105. PubMed ID: 28554223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment.
    Mocanu E; Redmond ML; Hennelly B; Collins C; Harrison R
    Hum Fertil (Camb); 2007 Sep; 10(3):175-81. PubMed ID: 17786650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: "tap early and often" versus hospitalization.
    Csokmay JM; Yauger BJ; Henne MB; Armstrong AY; Queenan JT; Segars JH
    Fertil Steril; 2010 Jan; 93(1):167-73. PubMed ID: 18990389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
    Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
    Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conservative management of ovarian hyperstimulation syndrome.
    Morris RS; Miller C; Jacobs L; Miller K
    J Reprod Med; 1995 Oct; 40(10):711-4. PubMed ID: 8551473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management and obstetric outcome of ovarian hyperstimulation syndrome.
    Zareen N
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):86-90. PubMed ID: 18454892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Bellver J; Pellicer A
    Fertil Steril; 2009 Dec; 92(6):1803-10. PubMed ID: 19632675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
    Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
    West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
    Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
    Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of osmoregulation in the pathophysiology and management of severe ovarian hyperstimulation syndrome.
    Evbuomwan I
    Hum Fertil (Camb); 2013 Sep; 16(3):162-7. PubMed ID: 24047195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous ovarian hyperstimulation syndrome in a normal singleton pregnancy.
    Oztekin O; Soylu F; Tatli O
    Taiwan J Obstet Gynecol; 2006 Sep; 45(3):272-5. PubMed ID: 17175480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention and management of ovarian hyperstimulation syndrome.
    Chen CD; Chen SU; Yang YS
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):817-27. PubMed ID: 22647872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive outpatient treatment of ovarian hyperstimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization.
    Lincoln SR; Opsahl MS; Blauer KL; Black SH; Schulman JD
    J Assist Reprod Genet; 2002 Apr; 19(4):159-63. PubMed ID: 12036082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian hyperstimulation syndrome and heterotopic pregnancy after IVF.
    Prapas Y; Prapas N; Chatziparasidou A; Konstantinou P; Vlassis G
    Acta Eur Fertil; 1994; 25(6):331-3. PubMed ID: 8838872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium infusion for the prevention of ovarian hyperstimulation syndrome: a double-blind randomized controlled trial.
    El-Khayat W; Elsadek M
    Fertil Steril; 2015 Jan; 103(1):101-5. PubMed ID: 25552412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent megalocystic ovary following in vitro fertilization in a postpartum patient with polycystic ovarian syndrome.
    Ling SY; Chong KM; Hwang JL
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):70-2. PubMed ID: 17272214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous abdominal paracentesis for management of late type severe ovarian hyperstimulation syndrome.
    Chan CC; Yin CS; Lan SC; Chen IC; Wu GJ
    J Chin Med Assoc; 2004 Apr; 67(4):197-9. PubMed ID: 15244020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.